MARSHALL WACE, LLP - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 113 filers reported holding INTERSECT ENT INC in Q4 2020. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q1 2022$3,390,000
+89.4%
121,032
+84.6%
0.01%
+100.0%
Q4 2021$1,790,000
+248.2%
65,558
+118.0%
0.00%
+50.0%
Q2 2021$514,000
+102.4%
30,076
+93.1%
0.00%0.0%
Q3 2020$254,000
-89.4%
15,577
-81.6%
0.00%
-91.7%
Q4 2018$2,392,000
-47.5%
84,886
-46.5%
0.02%
+26.3%
Q3 2018$4,560,000
-11.1%
158,598
-47.4%
0.02%
-92.3%
Q1 2017$5,129,000
+1290.0%
301,698
+1455.1%
0.25%
+6100.0%
Q1 2016$369,00019,4000.00%
Other shareholders
INTERSECT ENT INC shareholders Q4 2020
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 186,561$5,364,0004.51%
First Light Asset Management, LLC 517,121$14,867,0002.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,147,950$61,754,0002.21%
HealthCor Management, L.P. 1,950,000$56,063,0001.86%
PURA VIDA INVESTMENTS, LLC 200,000$5,750,0001.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 112,000$2,469,0001.17%
Broadfin Capital, LLC 234,200$6,733,0000.99%
Lombard Odier Asset Management (USA) Corp 240,000$6,900,0000.51%
PURA VIDA INVESTMENTS, LLC 83,527$2,401,0000.50%
Rock Springs Capital Management LP 460,000$13,225,0000.48%
View complete list of INTERSECT ENT INC shareholders